Curevac AG, of Tubingen, Germany, appointed Alan Kimura head of its rare diseases department.

Nordic Nanovector ASA, of Oslo, Norway, appointed Lars Nieba interim CEO.

Nouscom GmbH, of Basel, Switzerland, appointed Marina Udier CEO and Patricia Delaite chief medical officer.

Summit Therapeutics plc, of Oxford U.K., appointed Robert W. Duggan executive chair of its board.

No Comments